Literature DB >> 5901525

Evidence for an immunological reaction of the host directed against its own actively growing primary tumor.

Z B Mikulska, C Smith, P Alexander.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5901525

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  19 in total

1.  Plasma cell and lymphocytic reaction in the Syrian hamster to transplanted homologous tumor cells transformed in vitro "spontaneously" or by SV 40.

Authors:  G T Diamandopoulos
Journal:  Arch Gesamte Virusforsch       Date:  1967

2.  Prevention of virus-induced neoplasms in mice through passive transfer of immunity by sensitized syngeneic lymphoid cells.

Authors:  L W Law; R C Ting; E Leckband
Journal:  Proc Natl Acad Sci U S A       Date:  1967-04       Impact factor: 11.205

3.  The cellular stromal reaction in malignant melanoma. A cytochemical investigation.

Authors:  G Burg; O Braun-Falco
Journal:  Arch Dermatol Forsch       Date:  1972

4.  RNA-induced immunity against a rat sarcoma.

Authors:  M V Londner; J C Morini; M T Font; S L Rabasa
Journal:  Experientia       Date:  1968-06-15

5.  Prospects for immunotherapy of cancer: experience in experimental systems.

Authors:  P Alexander
Journal:  Br Med J       Date:  1970-11-21

6.  Delayed cutaneous sensitivity reactions to autologous Burkitt lymphoma protein extract. Results of a prospective two and a half year study.

Authors:  A Z Bluming; J L Ziegler; L Fass; R B Herberman
Journal:  Clin Exp Immunol       Date:  1971-12       Impact factor: 4.330

7.  Immunity to malignant disease in man.

Authors:  G H Fairley
Journal:  Br Med J       Date:  1969-05-24

8.  Cytotoxic potential of different lymphoid cell populations against chromium-51 labelled tumour cells.

Authors:  G R Pearson; R J Hodes; S Friberg
Journal:  Clin Exp Immunol       Date:  1969-09       Impact factor: 4.330

9.  Tumour-specific antibodies in human malignant melanoma and their relationship to the extent of the disease.

Authors:  M G Lewis; R L Ikonopisov; R C Nairn; T M Phillips; G H Fairley; D C Bodenham; P Alexander
Journal:  Br Med J       Date:  1969-09-06

10.  Vaccination with syngeneic monoclonal anti-idiotype protects against a tumour challenge.

Authors:  P L Dunn; C A Johnson; J M Styles; S S Pease; C J Dean
Journal:  Immunology       Date:  1987-02       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.